Fusion Pharmaceuticals (FUSN) Stock Price, News & Analysis
Company Description
Fusion Pharmaceuticals (NASDAQ: FUSN) is classified in the biological product (except diagnostic) manufacturing industry within the Biological Products, (no Disgnostic Substances) sector and carries a market capitalization of $1.8B, ranking #2,378 among all listed U.S. companies by market cap.
This page collects what Stock Titan holds for FUSN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Fusion Pharmaceuticals (FUSN) stock last closed at $21.55. At a market capitalization of $1.8B, FUSN is classified as a small-cap stock with approximately 85.1M shares outstanding.
FUSN Rankings
Latest News
Fusion Pharmaceuticals has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, clinical trial, earnings. View all FUSN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
FUSN Company Profile & Sector Positioning
Fusion Pharmaceuticals (FUSN) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.